Access the full text.
Sign up today, get DeepDyve free for 14 days.
Q. Gao, Yang Jiang, Tian Ma, Fa-liang Zhu, Fei Gao, Pin Zhang, Chun Guo, Qun Wang, Xiaoyan Wang, Chunhong Ma, Yun Zhang, Wanjun Chen, Lining Zhang (2010)
A Critical Function of Th17 Proinflammatory Cells in the Development of Atherosclerotic Plaque in MiceThe Journal of Immunology, 185
(2008)
The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat
Benjamin Clarkson, Changying Ling, Yejie Shi, Melissa Harris, A. Rayasam, Dandan Sun, M. Salamat, V. Kuchroo, John Lambris, M. Sandor, Z. Fabry (2014)
T cell–derived interleukin (IL)-21 promotes brain injury following stroke in miceThe Journal of Experimental Medicine, 211
Emily Smith, Konkal-Matt Prasad, M. Butcher, A. Dobrian, J. Kolls, K. Ley, E. Galkina (2010)
Blockade of Interleukin-17A Results in Reduced Atherosclerosis in Apolipoprotein E–Deficient MiceCirculation, 121
O. Boer, J. Meer, P. Teeling, C. Loos, M. Idu, F. Maldegem, J. Aten, A. Wal (2010)
Differential expression of interleukin‐17 family cytokines in intact and complicated human atherosclerotic plaquesThe Journal of Pathology, 220
C. Leonardi, R. Matheson, C. Zachariae, G. Cameron, Linda Li, E. Edson-Heredia, D. Braun, Subhashish Banerjee (2012)
Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis.The New England journal of medicine, 366 13
Jianjun Yang, Rui-hua Zhang, Geming Lu, Yu-Fei Shen, Liang Peng, Chen Zhu, M. Cui, Weidong Wang, P. Arnaboldi, Meng Tang, Monica Gupta, Chen-feng Qi, Padmini Jayaraman, Hongfa Zhu, Bo Jiang, Shu-Hsia Chen, J. He, A. Ting, Mingming Zhou, V. Kuchroo, H. Morse, K. Ozato, A. Sikora, H. Xiong (2013)
T cell–derived inducible nitric oxide synthase switches off TH17 cell differentiationThe Journal of Experimental Medicine, 210
K. Savvatis, Kathleen Pappritz, P. Becher, D. Lindner, C. Zietsch, H. Volk, D. Westermann, H. Schultheiss, C. Tschöpe (2014)
Interleukin-23 Deficiency Leads to Impaired Wound Healing and Adverse Prognosis After Myocardial InfarctionCirculation: Heart Failure, 7
C. Erbel, Lili Chen, F. Bea, Susanne Wangler, S. Çelik, F. Lasitschka, Ying Wang, D. Böckler, H. Katus, T. Dengler (2009)
Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice1The Journal of Immunology, 183
Eva Acosta-Rodriguez, G. Napolitani, A. Lanzavecchia, F. Sallusto (2007)
Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.Nature immunology, 8 9
P. Ponnuswamy, Emily Vré, Z. Mallat, A. Tedgui (2012)
Humoral and cellular immune responses in atherosclerosis: spotlight on B- and T-cells.Vascular pharmacology, 56 5-6
Fumitake Usui, Hiroaki Kimura, Taichi Ohshiro, Kazuki Tatsumi, A. Kawashima, Akiyo Nishiyama, Yoichirou Iwakura, S. Ishibashi, Masafumi Takahashi (2012)
Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice.Biochemical and biophysical research communications, 420 1
Tian Ma, Q. Gao, Fa-liang Zhu, Chun Guo, Qun Wang, Fei Gao, Lining Zhang (2013)
Th17 cells and IL-17 are involved in the disruption of vulnerable plaques triggered by short-term combination stimulation in apolipoprotein E-knockout miceCellular and Molecular Immunology, 10
Melanie Dart, E. Jankowska‐Gan, Guorui Huang, D. Roenneburg, M. Keller, J. Torrealba, Aaron Rhoads, Byoungjae Kim, J. Bobadilla, L. Haynes, D. Wilkes, W. Burlingham, D. Greenspan (2010)
Interleukin-17–Dependent Autoimmunity to Collagen Type V in AtherosclerosisCirculation Research, 107
Y. Liao, Ni Xia, Su-feng Zhou, T. Tang, Xinxin Yan, Bing-Jie Lv, Shaofang Nie, Jing Wang, Y. Iwakura, Hong Xiao, Jing Yuan, Harish Jevallee, Fen Wei, G. Shi, Xiang Cheng (2012)
Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration.Journal of the American College of Cardiology, 59 4
(2008)
Impaired t(h)17 cell differentiation in subjects with autosomal dominant hyper-ige syndrome
P. Libby (2002)
Inflammation in atherosclerosisNature, 420
Xiaoxiang Yan, T. Shichita, Yoshinori Katsumata, Tomohiro Matsuhashi, Hideyuki Ito, Kentaro Ito, Atsushi Anzai, J. Endo, Yuichi Tamura, Kensuke Kimura, J. Fujita, K. Shinmura, Weifeng Shen, A. Yoshimura, K. Fukuda, M. Sano (2012)
Deleterious Effect of the IL-23/IL-17A Axis and γδT Cells on Left Ventricular Remodeling After Myocardial InfarctionJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 1
Naoto Sasaki, T. Yamashita, Masafumi Takeda, M. Shinohara, K. Nakajima, Hideto Tawa, T. Usui, K. Hirata (2009)
Oral Anti-CD3 Antibody Treatment Induces Regulatory T Cells and Inhibits the Development of Atherosclerosis in MiceCirculation, 120
W. Ouyang, J. Kolls, Yan Zheng
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
C. Ryan, C. Leonardi, J. Krueger, A. Kimball, B. Strober, K. Gordon, R. Langley, J. Lemos, Yahya Daoud, D. Blankenship, S. Kazi, D. Kaplan, V. Friedewald, A. Menter (2011)
Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials.JAMA, 306 8
C. Lahoute, Olivier Herbin, Z. Mallat, A. Tedgui (2011)
Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targetsNature Reviews Cardiology, 8
(2011)
The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells
Xiang Cheng, Xian Yu, Ying-jun Ding, Qing-qing Fu, Jiang-jiao Xie, T. Tang, Rui Yao, Yong Chen, Y. Liao (2008)
The Th17/Treg imbalance in patients with acute coronary syndrome.Clinical immunology, 127 1
Mohamed El-behi, B. Ciric, H. Dai, Yaping Yan, M. Cullimore, F. Safavi, Guang-Xian Zhang, B. Dittel, A. Rostami (2011)
The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSFNature Immunology, 12
Liang Zhou, M. Chong, D. Littman (2009)
Plasticity of CD4+ T cell lineage differentiation.Immunity, 30 5
Deanna Mele, A. Salmeron, Srimoyee Ghosh, Hon-Ren Huang, Barbara Bryant, J. Lora (2013)
BET bromodomain inhibition suppresses TH17-mediated pathologyThe Journal of Experimental Medicine, 210
Fuping Zhang, Guangxun Meng, W. Strober (2008)
Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17–producing T cellsNature Immunology, 9
(2009)
Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury
Xuyu Zhou, Samantha Bailey-bucktrout, L. Jeker, C. Penaranda, M. Martínez‐Llordella, Meredith Ashby, M. Nakayama, Wendy Rosenthal, J. Bluestone (2009)
Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivoNature Immunology, 10
Xiang Cheng, S. Taleb, Jun Wang, T. Tang, Jian Chen, Xing-li Gao, Rui Yao, Jiang-jiao Xie, Xian Yu, Ni Xia, Xinxin Yan, Shaofang Nie, Meng-yang Liao, Yan Cheng, Z. Mallat, Y. Liao (2011)
Inhibition of IL-17A in atherosclerosis.Atherosclerosis, 215 2
P. Miossec, T. Korn, V. Kuchroo (2009)
Interleukin-17 and type 17 helper T cells.The New England journal of medicine, 361 9
Raymond Eid, Deepak Rao, Jing Zhou, S. Lo, Hooman Ranjbaran, A. Gallo, Seth Sokol, S. Pfau, J. Pober, G. Tellides (2009)
Interleukin-17 and Interferon-γ Are Produced Concomitantly by Human Coronary Artery–Infiltrating T Cells and Act Synergistically on Vascular Smooth Muscle CellsCirculation, 119
M. Gelderblom, A. Weymar, C. Bernreuther, J. Velden, Priyadharshini Arunachalam, K. Steinbach, E. Orthey, T. Arumugam, F. Leypoldt, O. Simova, V. Thom, M. Friese, I. Prinz, C. Hölscher, M. Glatzel, T. Korn, C. Gerloff, E. Tolosa, T. Magnus (2012)
Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke.Blood, 120 18
William O'Connor, M. Kamanaka, C. Booth, T. Town, S. Nakae, Y. Iwakura, J. Kolls, R. Flavell (2009)
A protective function for interleukin 17A in T cell–mediated intestinal inflammationNature Immunology, 10
Barbara Schraml, K. Hildner, W. Ise, Wan-Ling Lee, W. Smith, Ben Solomon, G. Sahota, Julia Sim, R. Mukasa, S. Cemerski, R. Hatton, G. Stormo, C. Weaver, J. Russell, T. Murphy, K. Murphy (2009)
The AP-1 transcription factor Batf controls TH17 differentiationNature, 460
A. Gisterå, A. Robertson, J. Andersson, D. Ketelhuth, O. Ovchinnikova, S. Nilsson, Anna Lundberg, Ming Li, R. Flavell, G. Hansson (2014)
Transforming growth factor-beta signaling in t cells promotes stabilization of atherosclerotic plaques through an interleukin-17 dependent pathwayAtherosclerosis, 235
Serge Pavert, Manuela Ferreira, Rita Domingues, Hélder Ribeiro, R. Molenaar, Lara Moreira-Santos, Francisca Almeida, S. Ibiza, I. Barbosa, G. Goverse, Carlos Labão-Almeida, Cristina Godinho-Silva, T. Konijn, Dennis Schooneman, T. O’Toole, Mark Mizee, Y. Habani, E. Haak, F. Santori, D. Littman, S. Schulte-Merker, E. Dzierzak, J. Simas, R. Mebius, H. Veiga-Fernandes (2014)
Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunityNature, 508
D. Moody, A. Jong (2012)
Faculty Opinions recommendation of Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.
C. Griffiths, B. Strober, P. Kerkhof, V. Ho, R. Fidelus-Gort, N. Yeilding, C. Guzzo, Yichuan Xia, Bei Zhou, Shu Li, L. Dooley, N. Goldstein, A. Menter (2010)
Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis.The New England journal of medicine, 362 2
L. Rogge (2008)
Faculty Opinions recommendation of IL-21 and TGF-beta are required for differentiation of human T(H)17 cells.
N. Komatsu, Kazuo Okamoto, S. Sawa, T. Nakashima, M. Oh‐hora, T. Kodama, Sakae Tanaka, J. Bluestone, H. Takayanagi (2013)
Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritisNature Medicine, 20
M. McGeachy, K. Bak-Jensen, Yi Chen, C. Tato, W. Blumenschein, T. Mcclanahan, D. Cua (2007)
TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell–mediated pathologyNature Immunology, 8
Markus Kleinewietfeld, A. Manzel, J. Titze, H. Kvakan, N. Yosef, R. Linker, D. Muller, D. Hafler (2013)
Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cellsNature, 496
S. Vietinghoff, E. Koltsova, J. Mestas, Cody Diehl, J. Witztum, K. Ley (2011)
Mycophenolate mofetil decreases atherosclerotic lesion size by depression of aortic T-lymphocyte and interleukin-17-mediated macrophage accumulation.Journal of the American College of Cardiology, 57 21
B. Schnyder, S. Schnyder‐Candrian, A. Pansky, M. Schmitz, M. Heim, B. Ryffel, R. Moser (2005)
IL-17 reduces TNF-induced Rantes and VCAM-1 expression.Cytokine, 31 3
Yi Chen, C. Langrish, Brent McKenzie, B. Joyce-Shaikh, J. Stumhofer, T. Mcclanahan, W. Blumenschein, Tatyana Churakovsa, Justin Low, L. Presta, C. Hunter, R. Kastelein, D. Cua (2006)
Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis.The Journal of clinical investigation, 116 5
K. Ghoreschi, A. Laurence, Xiang-Ping Yang, C. Tato, M. McGeachy, J. Konkel, Haydeé Ramos, Lai Wei, Todd Davidson, N. Bouladoux, J. Grainger, Qian Chen, Y. Kanno, W. Watford, Hong-Wei Sun, G. Eberl, E. Shevach, Y. Belkaid, D. Cua, Wanjun Chen, J. O’Shea (2010)
Generation of Pathogenic Th17 Cells in the Absence of TGF-β SignalingNature, 467
H. Takatori, Y. Kanno, W. Watford, C. Tato, Greta Weiss, I. Ivanov, D. Littman, J. O’Shea (2009)
Lymphoid tissue inducer–like cells are an innate source of IL-17 and IL-22The Journal of Experimental Medicine, 206
S. Ge, B. Hertel, E. Koltsova, I. Sörensen-Zender, J. Kielstein, K. Ley, H. Haller, S. Vietinghoff (2013)
Increased Atherosclerotic Lesion Formation and Vascular Leukocyte Accumulation in Renal Impairment Are Mediated by Interleukin-17ACirculation Research, 113
E. Esplugues, S. Huber, N. Gagliani, A. Hauser, T. Town, Y. Wan, William O'Connor, A. Rongvaux, N. Rooijen, A. Haberman, Y. Iwakura, V. Kuchroo, J. Kolls, J. Bluestone, K. Herold, R. Flavell (2011)
Control of TH17 cells occurs in the Small IntestineNature, 475
Youjin Lee, A. Awasthi, N. Yosef, F. Quintana, S. Xiao, A. Peters, Chuan Wu, Markus Kleinewietfeld, Sharon Kunder, D. Hafler, R. Sobel, A. Regev, V. Kuchroo (2012)
Induction and molecular signature of pathogenic TH17 cellsNature immunology, 13
Hoyong Lim, Young Kim, Hua Sun, Joyce Lee, J. Reynolds, S. Hanabuchi, Huaizhu Wu, B. Teng, Yeonseok Chung (2014)
Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo.Immunity, 40 1
M. Madhur, S. Funt, Li Li, Antony Vinh, Wei Chen, Heinrich Lob, Y. Iwakura, Yelena Blinder, Ayaz Rahman, A. Quyyumi, D. Harrison (2011)
Role of Interleukin 17 in Inflammation, Atherosclerosis, and Vascular Function in Apolipoprotein E–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 31
Emily Smith, Matthew Stark, A. Zarbock, Tracy Burcin, Anthony Bruce, Devin Vaswani, P. Foley, K. Ley (2008)
IL-17A Inhibits the Expansion of IL-17A-Producing T Cells in Mice through “Short-Loop” Inhibition via IL-17 Receptor1The Journal of Immunology, 181
P. Libby, A. Lichtman, G. Hansson (2013)
Immune effector mechanisms implicated in atherosclerosis: from mice to humans.Immunity, 38 6
Satwat Hashmi, Q. Zeng (2006)
Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery diseaseCoronary Artery Disease, 17
Benjamin Marks, Heba Nowyhed, Jin-Young Choi, Amanda Poholek, J. Odegard, R. Flavell, J. Craft (2009)
Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammationNature immunology, 10
H. Qin, Lanfang Wang, Ting Feng, C. Elson, S. Niyongere, Sun Lee, Stephanie Reynolds, C. Weaver, K. Roarty, R. Serra, E. Benveniste, Y. Cong (2009)
TGF-β Promotes Th17 Cell Development through Inhibition of SOCS31The Journal of Immunology, 183
H. Ogura, M. Murakami, Y. Okuyama, M. Tsuruoka, C. Kitabayashi, M. Kanamoto, M. Nishihara, Y. Iwakura, T. Hirano (2008)
Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction.Immunity, 29 4
J. Berzofsky (2007)
Faculty Opinions recommendation of TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.
Jyoti Das, G. Ren, Liying Zhang, A. Roberts, Xin Zhao, A. Bothwell, L. Kaer, Yufang Shi, G. Das (2009)
Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiationThe Journal of Experimental Medicine, 206
A. Tedgui, Z. Mallat (2006)
Cytokines in atherosclerosis: pathogenic and regulatory pathways.Physiological reviews, 86 2
K. Papp, C. Leonardi, A. Menter, J. Ortonne, J. Krueger, G. Kricorian, Girish Aras, Juan Li, C. Russell, E. Thompson, S. Baumgartner (2012)
Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis.The New England journal of medicine, 366 13
Liang Zhou, I. Ivanov, R. Spolski, Roy Min, K. Shenderov, Takeshi Egawa, D. Levy, W. Leonard, D. Littman (2007)
IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathwaysNature Immunology, 8
J. Kolls, A. Lindén (2004)
Interleukin-17 family members and inflammation.Immunity, 21 4
R. Noster, R. Riedel, M. Mashreghi, H. Radbruch, Lutz Harms, C. Haftmann, Hyun-Dong Chang, Andreas Radbruch, C. Zielinski (2014)
IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper CellsScience Translational Medicine, 6
E. Volpe, N. Servant, Raphaël Zollinger, S. Bogiatzi, P. Hupé, E. Barillot, V. Soumelis (2008)
A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responsesNature Immunology, 9
T. Es, G. Puijvelde, O. Ramos, F. Segers, L. Joosten, W. Berg, I. Michon, P. Vos, T. Berkel, J. Kuiper (2009)
Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.Biochemical and biophysical research communications, 388 2
S. Taleb, Melissa Romain, Bhama Ramkhelawon, C. Uyttenhove, G. Pasterkamp, Olivier Herbin, B. Esposito, Nicolas Pérez, H. Yasukawa, J. Snick, A. Yoshimura, A. Tedgui, Z. Mallat (2009)
Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosisThe Journal of Experimental Medicine, 206
S. Gaffen (2009)
Structure and signalling in the IL-17 receptor familyNature Reviews Immunology, 9
Z. Mallat, H. Ait-Oufella, A. Tedgui (2005)
Regulatory T cell responses: potential role in the control of atherosclerosisCurrent Opinion in Lipidology, 16
R. Klingenberg, N. Gerdes, R. Badeau, A. Gisterå, D. Strodthoff, D. Ketelhuth, Anna Lundberg, M. Rudling, S. Nilsson, G. Olivecrona, S. Zoller, C. Lohmann, T. Lüscher, M. Jauhiainen, T. Sparwasser, G. Hansson (2013)
Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis.The Journal of clinical investigation, 123 3
R. Caspi, R. Horai (2011)
Faculty Opinions recommendation of Fate mapping of IL-17-producing T cells in inflammatory responses.
Matthew Ruddy, Grace Wong, Xikui Liu, Hiroyasu Yamamoto, S. Kasayama, K. Kirkwood, S. Gaffen (2004)
Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members*Journal of Biological Chemistry, 279
I. Gutcher, Moses Donkor, Q. Ma, A. Rudensky, R. Flavell, Ming Li (2011)
Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation.Immunity, 34 3
A. Jäger, V. Dardalhon, R. Sobel, E. Bettelli, V. Kuchroo (2009)
Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes1The Journal of Immunology, 183
M. Butcher, Breanne Gjurich, Tracy Phillips, E. Galkina (2012)
The IL-17A/IL-17RA Axis Plays a Proatherogenic Role via the Regulation of Aortic Myeloid Cell RecruitmentCirculation Research, 110
C. Erbel, T. Dengler, Susanne Wangler, F. Lasitschka, F. Bea, N. Wambsganss, M. Hakimi, D. Böckler, H. Katus, C. Gleissner (2010)
Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerabilityBasic Research in Cardiology, 106
E. Bettelli, T. Korn, M. Oukka, V. Kuchroo (2008)
Induction and effector functions of TH17 cellsNature, 453
G. Ho (2015)
Faculty Opinions recommendation of Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology.
Sivareddy Kotla, Nikhlesh Singh, M. Heckle, G. Tigyi, G. Rao (2013)
The Transcription Factor CREB Enhances Interleukin-17A Production and Inflammation in a Mouse Model of AtherosclerosisScience Signaling, 6
T. Simon, S. Taleb, N. Danchin, L. Laurans, B. Rousseau, S. Cattan, J. Montély, O. Dubourg, A. Tedgui, S. Kotti, Z. Mallat (2013)
Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction.European heart journal, 34 8
ATVB in Focus Modulation of Atherosclerotic Lesions by Circulating Cells: The Translational Spectrum Series Editors: Theo J. van Berkel and Johan Kuiper IL-17 and Th17 Cells in Atherosclerosis Subtle and Contextual Roles Soraya Taleb, Alain Tedgui, Ziad Mallat Abstract—Atherosclerosis is a chronic inflammatory arterial disease driven by both innate and adaptive immune responses to modified lipoproteins and components of the injured vascular wall. Specific T lymphocyte responses driven by T helper-1 or T regulatory cells play distinct and opposing roles in atherosclerosis. More recently, T helper-17 cells, which produce the prototype cytokine interleukin-17, have been characterized and shown to be critical in mucosal host defense against microbial and fungal pathogens. Sustained production of interleukin-17 in an inflammatory context has been linked to the pathology of several autoimmune and inflammatory diseases. However, regulatory and protective roles have also been reported in selective disease settings. Studies in atherosclerosis led to conflicting results on the roles of interleukin-17 and T helper-17 cells in disease development and plaque stability. The present review provides a summary of the available evidence and putative mechanisms linking this pathway to atherosclerosis, as well as a perspective on the risks and benefits of interleukin-17–targeted cytokine therapy in patients
Arteriosclerosis, Thrombosis, and Vascular Biology – Wolters Kluwer Health
Published: Feb 1, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.